- Home
- VABK vs INBX Comparison
VABK vs INBX Comparison
Compare VABK & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VABK
- INBX
- Stock Information
- Founded
- VABK 1998
- INBX 2010
- Country
- VABK United States
- INBX United States
- Employees
- VABK N/A
- INBX N/A
- Industry
- VABK Major Banks
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- VABK Finance
- INBX Health Care
- Exchange
- VABK Nasdaq
- INBX Nasdaq
- Market Cap
- VABK 199.2M
- INBX 178.5M
- IPO Year
- VABK N/A
- INBX 2020
- Fundamental
- Price
- VABK $37.50
- INBX $23.50
- Analyst Decision
- VABK
- INBX Hold
- Analyst Count
- VABK 0
- INBX 1
- Target Price
- VABK N/A
- INBX N/A
- AVG Volume (30 Days)
- VABK 5.9K
- INBX 138.8K
- Earning Date
- VABK 07-22-2025
- INBX 08-12-2025
- Dividend Yield
- VABK 3.84%
- INBX N/A
- EPS Growth
- VABK 3.77
- INBX N/A
- EPS
- VABK 3.30
- INBX 111.58
- Revenue
- VABK $54,953,000.00
- INBX $200,000.00
- Revenue This Year
- VABK N/A
- INBX N/A
- Revenue Next Year
- VABK N/A
- INBX N/A
- P/E Ratio
- VABK $11.35
- INBX $0.22
- Revenue Growth
- VABK 1.60
- INBX N/A
- 52 Week Low
- VABK $33.53
- INBX $10.80
- 52 Week High
- VABK $44.00
- INBX $24.42
- Technical
- Relative Strength Index (RSI)
- VABK 54.87
- INBX 87.77
- Support Level
- VABK $37.00
- INBX $20.48
- Resistance Level
- VABK $38.48
- INBX $24.30
- Average True Range (ATR)
- VABK 0.76
- INBX 1.45
- MACD
- VABK 0.01
- INBX 0.56
- Stochastic Oscillator
- VABK 73.71
- INBX 94.04
About VABK Virginia National Bankshares Corporation
Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.